Mitochondria are multifunctional subcellular organelles
whose operations
encompass energy production, signal transduction, and metabolic regulation.
Given their wide range of roles, they have been studied extensively
as a potential therapeutic target for the treatment of various diseases,
including cancer, diabetes, and neurodegenerative diseases. Mitochondrion-mediated
pathways have been identified as promising targets in the context
of these diseases. However, the delivery of specific probes and drugs
to the mitochondria is one of the major problems that remains to be
solved. Over the past decade, much effort has been devoted to developing
mitochondrion-targeted delivery methods based on the membrane characteristics
and the protein import machinery of mitochondria. While various methods
utilizing small molecules to polymeric particles have been introduced,
it is notable that many of these compounds share common structural
elements and physicochemical properties for optimal selectivity and
efficiency. In this Perspective, we will review the most recently
developed mitochondrion-targeting peptides and peptidomimetics to
outline the key aspects of structural requirements and design principles.
We will also discuss successful and potential applications of mitochondrial
delivery to assess opportunities and challenges in the targeting of
mitochondria.